Found: 28
Select item for more details and to access through your institution.
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 477, doi. 10.1093/jac/dkad376
- By:
- Publication type:
- Article
Factors associated with inappropriateness of antibiotic prescriptions for acutely ill children presenting to ambulatory care in high-income countries: a systematic review and meta-analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 498, doi. 10.1093/jac/dkad383
- By:
- Publication type:
- Article
Early-career general practitioners' antibiotic prescribing for acute infections: a systematic review.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 512, doi. 10.1093/jac/dkae002
- By:
- Publication type:
- Article
The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 526, doi. 10.1093/jac/dkad370
- By:
- Publication type:
- Article
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 531, doi. 10.1093/jac/dkad402
- By:
- Publication type:
- Article
Detection of CTX-M-15 ESBL in XDR Haemophilus parainfluenzae from a urethral swab.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 539, doi. 10.1093/jac/dkad408
- By:
- Publication type:
- Article
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 546, doi. 10.1093/jac/dkad412
- By:
- Publication type:
- Article
Association between piperacillin/tazobactam use and acute kidney injury in critically ill patients: a retrospective multicentre cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 552, doi. 10.1093/jac/dkae001
- By:
- Publication type:
- Article
Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 559, doi. 10.1093/jac/dkae004
- By:
- Publication type:
- Article
Cerebrospinal fluid concentrations of posaconazole in paediatric leukaemia patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 564, doi. 10.1093/jac/dkae005
- By:
- Publication type:
- Article
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 567, doi. 10.1093/jac/dkae006
- By:
- Publication type:
- Article
Use of genotypic HIV DNA testing: a DELPHI-type consensus.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 578, doi. 10.1093/jac/dkae007
- By:
- Publication type:
- Article
Incidence of amoxycillin-clavulanic acid associated hepatotoxicity in an Australian children's hospital.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 589, doi. 10.1093/jac/dkae009
- By:
- Publication type:
- Article
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 595, doi. 10.1093/jac/dkae011
- By:
- Publication type:
- Article
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 608, doi. 10.1093/jac/dkae012
- By:
- Publication type:
- Article
Riparin II-type benzamides as novel antibiofilm agents against dermatophytes: chemical synthesis, in vitro, ex vivo and in silico evaluation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 617, doi. 10.1093/jac/dkae013
- By:
- Publication type:
- Article
Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey data.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 632, doi. 10.1093/jac/dkae015
- By:
- Publication type:
- Article
Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 641, doi. 10.1093/jac/dkae021
- By:
- Publication type:
- Article
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 648, doi. 10.1093/jac/dkae022
- By:
- Publication type:
- Article
Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 656, doi. 10.1093/jac/dkae023
- By:
- Publication type:
- Article
Linezolid brain penetration in neurointensive care patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 669, doi. 10.1093/jac/dkae025
- By:
- Publication type:
- Article
Novel multidrug resistance genomic islands and transposon carrying bla<sub>VEB-1</sub> identified in mcr-positive Aeromonas strains from raw meat in China.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 678, doi. 10.1093/jac/dkae031
- By:
- Publication type:
- Article
Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 683, doi. 10.1093/jac/dkad400
- By:
- Publication type:
- Article
Comparison of ETEST<sup>®</sup> superposition method and the MTS<sup>™</sup> Aztreonam-avibactam strip with the reference method for aztreonam/avibactam susceptibility testing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 685, doi. 10.1093/jac/dkad407
- By:
- Publication type:
- Article
Disseminated invasive Corynebacterium simulans infection complicated by high-level daptomycin resistance acquisition under treatment: a case report.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 687, doi. 10.1093/jac/dkad409
- By:
- Publication type:
- Article
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 689, doi. 10.1093/jac/dkad410
- By:
- Publication type:
- Article
Comment on: Identifying a therapeutic target for vancomycin against staphylococci in young infants.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 692, doi. 10.1093/jac/dkae014
- By:
- Publication type:
- Article
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria—authors' response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 692, doi. 10.1093/jac/dkad411
- By:
- Publication type:
- Article